PSMA-targeted PET with [68Ga]Ga-P16-093: Assessment of potential role in surgical planning for patients with intermediate-risk and high-risk prostate cancer.

Conclusions: [68Ga]Ga-P16-093 appears useful for pre-prostatectomy assessment of patients with intermediate- or high-risk prostate cancer to better define the regional location(s) of disease. In this initial assessment, PET-derived knowledge of regional PSMA expression would have modified surgical planning in 6 of the 10 patients. (Supported by NIH/NCI R44CA233140.)

Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Bahler, C., Tann, M., Green, M., Hutchins, G., Mathias, C., Whaley, R., Cheng, L., Alexoff, D., Kung, H. Tags: GU - PSMA PET (Poster Session) Source Type: research